CD274 and non-small cell lung carcinoma: Subsequently, several investigations including a large-scale comparative study by Cortellini and colleagues found that ATB exposure significantly reduced the median PFS and OS in NSCLC patients with high PD-L1 expression undergoing pembrolizumab monotherapy [59].